[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  BowTiedBiotech π§ͺπ¬π§¬ [@BowTiedBiotech](/creator/twitter/BowTiedBiotech) on x 19.6K followers Created: 2025-07-21 11:43:20 UTC 2/ 2025β2027: The industrial era begins β 20+ ADC approvals by YE 2027 β Site-specific conjugation becomes the standard β Daiichi, Pfizer ramp 3β4Γ manufacturing capacity β $15B market with 9β10% CAGR This is no longer boutique biotech. Itβs scaled oncology infrastructure.  XXX engagements  **Related Topics** [$15b](/topic/$15b) [$8750t](/topic/$8750t) [$pfe](/topic/$pfe) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/BowTiedBiotech/status/1947261104939299269)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BowTiedBiotech π§ͺπ¬π§¬ @BowTiedBiotech on x 19.6K followers
Created: 2025-07-21 11:43:20 UTC
2/ 2025β2027: The industrial era begins
β 20+ ADC approvals by YE 2027
β Site-specific conjugation becomes the standard
β Daiichi, Pfizer ramp 3β4Γ manufacturing capacity
β $15B market with 9β10% CAGR
This is no longer boutique biotech. Itβs scaled oncology infrastructure.
XXX engagements
Related Topics $15b $8750t $pfe stocks healthcare
/post/tweet::1947261104939299269